Nanjing Pharmaceutical Factory

Nanjing Pharmaceutical Factory Co., Ltd. is a long-standing Chinese pharmaceutical manufacturer founded in 1935, specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company focuses on several core therapeutic areas, including oncology, cardiovascular health, and anesthesiology, with a significant portfolio of generic drugs and high-quality APIs exported globally. As a subsidiary of the Red Sun Group, it operates large-scale manufacturing facilities that comply with international GMP standards, including US FDA and EU GMP certifications. The firm provides contract manufacturing services and is recognized for its production of critical drugs such as Ifosfamide and Milrinone.